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ABSTRACT 
Objective: To isolate steroidal compound from Cleome droserifolia and explore its activity against tumour necrosis factor (TNF) using molecular 
docking studies. 
Methods: Extraction of the plant material was carried using two successive solvents and three compounds were isolated using column 
chromatography. The isolated compounds were identified using different spectroscopic data such as 1D, 2D nuclear magnetic resonance (NMR), 
ultraviolet-visible spectroscopy (UV-Visible), fourier transform infrared spectroscopy (FT-IR) and electrospray ionization mass spectroscopy (ESI-
MS). Molecular docking was carried in order to investigate the activity of the ergostane derivative as tumour necrosis factor inhibitor. 
Results: Two steroidal compounds were isolated and identified as ergost-5,7,9,24 (28)-tetraen-3-one (1) and β-sitosterol glucoside (3) by means of 
spectroscopic measurement. 1-dodecanol (2) was also isolated. The ergostane derivative showed several binding sites with TNF-α 
Conclusion: The new ergostane derivative isolated from the aerial parts of Cleome droserifolia is introduced to serve as a potential tumour necrosis 
factor inhibitor and may be used as a lead compound for the treatment of rheumatoid arthritis. 
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Cleome droserifolia is traditionally used in Egypt as a hypoglycaemic 
healing remedy as proven via several in vivo and clinical studies [1, 
2]. The phytochemical investigation of the plant had revealed that it 
is rich in diverse chemical entities; as several research studies 
described the isolation of different classes of terpenes mainly, 
sesquiterpenes, diterpenes and triterpenes [1-4]. The literature also 
reported the isolation of a number of flavones (methoxylated ones 
as well as flavone glycosides). Furthermore, volatile oil, sterols, 
hydrocarbons and a glucosinolate (glucocapparin) were also 
reported [1, 3].  
Our earlier work on C. droserifolia has described the isolation of 
sesquiterpenes, dolabellane diterpenes and flavonoids [2, 4]. The 
paucity of information on the chemical constitution of this plant 
extract has encouraged us to explore other chemical entities giving 
emphasis on phytochemical analysis of the medium polar fractions 
where additional chemical structures may reside.  
About 3% of the world population suffer from autoimmune diseases 
and their conventional treatment always relied on immune-
suppressive therapies. However, advances in understanding the 
cellular activity pathways have led to new therapeutic treatments 
targeting defined pathways of the adaptive immune response such as 
tumour necrosis factor-alpha inhibitors (TNF-α) [5]. 
TNF-α is a protein involved in inflammation processes and immune 
response. Its overproduction leads to the development of chronic 
autoimmune diseases. Its role seems to be immune-regulatory that 
can change the balance of T regulatory cells and regulate acute 
immunological responses [5]. Inhibition of TNF production or 
function by small molecules has become a major focus in the 
pharmaceutical industry for the treatment of rheumatoid arthritis. 
But till date, only six drugs have been approved by FDA and they are 
all large protein monoclonal antibodies. Several natural products 
have been reported to inhibit TNF either in vitro or by 
computational docking studies. For instance, Ginseng saponins and 
14-dehydroergosterol [6-8]. This has encouraged us to investigate 
the activity of the isolated steroidal compound as a possible TNF 
inhibitor. 
C. droserifolia was collected from Wady Gnai; coordinates 
(28.453501 °, 34.448650 °); Dahab, Sinaii, Egypt and kindly 
identified by Professor Loutfy boulos, National Research Centre, 
Dokki, Cairo, Egypt. A voucher specimen (CD106) has been 
deposited in the Pharmacognosy department, Faculty of Pharmacy, 
Alexandria University, Egypt 
The air-dried powdered aerial parts of C. droserifolia (1 kg) were 
soaked in light petroleum, to give a dark green semisolid residue (52 
g). The residue was re-dissolved in light petroleum and then 
extracted with 90% methanol (MeOH) which afforded a brown 
aggregate (12g). The later residue was subjected to column 
chromatography using silica gel and eluting with hexane with 
increasing concentrations of methylene chloride (CH2Cl2
The defatted powdered plant material was air dried then extracted 
with acetone to give a semisolid brown residue (70 g). The residue 
was then fractionated according to a modified Kupshan fractionation 
scheme [4] which enabled us to isolate dolabellane diterpenes, 
methoxylated flaones, a flavan and flavonoidal glycosides in our 
previous studies [2,4]. The carbon tetrachloride fraction (30 g) was 
chromatographed on a silica gel column and the fraction eluted with 
50% ethyl acetate (EtOAc) in CHR2RClR2R (4 g) was re-chromatographed 
on a silica gel C18 column using 80% acetonitrile in water to isolate 
10 mg of (2). While 50 mg of (3) were precipitated from the fraction 
eluted with 5% MeOH in EtOAc. 
The 1D and 2D NMR analyses were obtained using a Jeol 500MHz 
spectrometer for 1H-and 125MHz for P13PCNMR. Residual peaks of the 
deuterated solvents were used to reference the spectrum. ESIMS 
was carried on a Finnigan LCQ. IR spectra were recorded as a film 
using a FTIR-8400S Fourier transform infrared spectrophotometer 
(Shimadzu). UV-visible spectra were carried on a Helios _ thermo-
spectronic, England, supported with Vision 32 software. 
NMR examination (table 1) revealed that compound 1 is 
characterised by having a steroidal nucleus (19 carbons atoms) in 
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addition to three doublet methyl signals at δ0.93 (H21), 0.83 (H26) 
and 0.74 part per million ppm (H27), designated to side chain 
methyls. Besides, additional two singlet methyl signals at δ0.90 
(H18) and 0.88 (H19) were attached to the sterol nucleus. 
). The first 
fraction eluted from the column contained libermann positive spot 
(25 mg) which was designated compound 1. 
The UV spectrum (λmax 350 nm in MeOH) revealed that it possessed 
a conjugated triene structure composed of Δ[5,6] and Δ[7,9], with an 
extra conjugated double bond which could be located in either 
position Δ9([11]) or Δ[14,15]. Comparing its spectral data with 
dehydroergosterol (DHE) and 14-DHE revealed that the position of 
the additional double bond was suggested to be located at C-9 as in 
dehydroergosterol. This suggestion was further confirmed by the 
presence of a correlation between the proton at 5.56 with C12 and 
C9 with H1 (HMBC). The resonance of the two double bond were 
evident in the IR spectrum as C=C stretching band at 1649 cm-1 in 
accordance with the value 1650-1655 cm-1 Kasal etal mentioned for 
5,7 diene steroidal structure. The B and C ring proton signals 
appeared at 5.56, 5.40, and 5.47 ppm in the 1HNMR. Two additional 
olefinic proton signals, resonating as two broad singlets at 4.5 and 
4.7 ppm were observed in the 1
The mass spectrum reveals a molecular ion peak M
HNMR and were assigned to the 
unsaturated alkyl side chain.  
+at m/z 392 
agreeing with formula C28H40
The IR spectrum indicated the absence of a hydroxyl group, as there 
was no peak observed at the region of 3300-3400 cm
O Additional peaks at m/z 348 (M-
isopropyl moiety), and a peak at m/z 265 corresponds to [M-side 
chain-2H]. 
-1. Meanwhile, 
the presence of a sharp peak detected at 1729 cm-1 implicating the 
possibility that position 3 is occupied by a carbonyl carbon in 
accordance to the value 1720 cm-1
 
 Kasal etal mentioned in their 
book for 3 non conjugated ketone ester sterol [9]. This was further 
supported by the absence of peaks involving the loss of water in the 
mass spectrum. The structure of the compound was thus suggested 
to be ergost-5,7,9,24 (28)-tetraen-3-one (fig. 1). 
Table 1: 1H, 13
Carbon 
CNMR spectral data for compounds (1-3) 
Compound 1 Compound 3’ Compound 2 
δ C δ H δ C δ H δ C δ H 
1 25.6 1.99 (2H,m) 37.5 1.69 (2H, m) 67.9 3.79 (2H, m) 
2 30.4 1.9 (1H, m) 30.3 1.71 (2H, m) 25.6 1.72 (2H, m) 
3 213 - 78.1 3.97 (1H, m) 22, 25, 34 1.2-1.5 (18 H,m) 
4 30.4 1.9 (1H, m) 39.3 2.4 (dt,J=11.4,2) 
2.6 (dd, j=10.7,2) 
14 0.85 (t, J=7,3H) 
5 136.3 - 140.9    
6 124.1 5.47 (d, J=1.6) 121.9 5.35 (d, 5.2)   
7 122.3 5.40 (d, J=1.6) 32.2 1.30 (2H,m)   
8 134.6 - 32.1 1.30 (1H, m)   
9 134.3 - 50.4 0.9 (1H, m)   
10 40.9 - 37.0 -   
11 121.4 5.56 (br s) 21.3 1.1 (2H, m)   
12 24.4 1.7 (1H, m) 40.0 1.9 (2H,m)   
13 42.5 - 42.5 -   
14 44.1 1.6 (1H, m) 57.0 1.1(1H, m)   
15 23.7* 1.72(1H, m) 24.5 1.3 (2H, m)   
16 29 1.3 (1H, m) 28.5 1.7(2H, m)   
17 46.8 1.21(1H, m) 56.3 1.1 (1H, m)   
18 21.6 0.90 (S,3H) 12.0 0.70 (3H, s)   
19 21.5 0.88 (S,3H) 19.4 1.00 (3H, s)   
20 39.0 1.72 (1H, m) 35.8 1.3 (1H,m)   
21 21.2 0.93 (d, J=6.9,3H) 18.9 0.84 (3H, d)   
22 36.2 2.36(1H, m) 
2.39(1H, m) 
34.0 1.7 (2H, m)   
23 26.1 2.18 (1H, m) 
2.16(1H, m) 
29.7 1.7 (2H, m)   
24 153.3 - 49.8 1.10 (1H, m)   
25 36.6 2.05 (1H, m) 28.7 -   
26 15.7 0.83 (d, J=6.9,3H) 18.0 0.83 (3H,S)  
27 15.0 0.74 (d, J=6.9,3H) 17.9 0.87 (3H,s)   
28 103.1 4.55 (d, J=1.6,1H) 
4.66 (d, J=1.6,1H) 
22.8 1.3 (2H,m)   
29   12.3 0.85 (3H,s)   
Sugar cabons C1   102.6 5.05 (d,, J=7)   
C2   75.3 4.05 (t, J=7.8)   
C3   78.6 4.27 (t, J=7.8)   
C4   71.7 4.30 (t, J=7.8)   
C5   78.4 3.97    
C6   62.8 4.56 (dd, J=11.7, 2.5) 




NMR spectra of compound 2 showed signals that clearly indicated 
the presence of fatty alkyl chain as it contained a methyl signal at δ 
0.85, (3H, t), Methylene protons at δ 1.2-1.5 (18H, br s) in addition to 
a methylene signal at (3.75) ppm.  
Apt spectrum showed the presence of carbon signals in the aliphatic 
region (10-40 ppm), in addition to an oxygenated methylene at 67.9 
ppm. ESIMS showed a prominent peak at m/z 203 equivalent to 
[M+NH3]P+ Psuggesting a molecular formula of C12H26O. The presence of 
a peak at 167 [M-OH] indicate loss of OH suggesting that it contained 
an alcoholic function group which was observed as broad peak at 3437 
cmP-1P and C-O stretching band at 1363 cmP-1P in the IR spectrum. The 
identity of the compound was ascertained to be dodecanol (lauryl 
alcohol) upon comparing its spectra with the previously reported 
one. It is worth mentioning that 3,7,11-trimethyldodeca-1,6,10-
triene was previously reported from C. Droserifolia [3]. 
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ESIMS spectra of compound 3 showed a peak at m/z 599 (576+Na) 
suggesting a molecular formula C35H60O6 and identified as β-
sitosterol glucoside by Comparing its 1D,2D NMR spectra and mass 
spectra with the previously reported [10]. The compound was also 
subjected to acid hydrolysis and the aglycone was identified as β-
sitosterol by means of spectroscopic data (NMR and ESIMS) as the 
carbon C-3 was shifted to 71.7 ppm and H-3 to 3.4 ppm indicating a 
free hydroxyl group. The sugar identity was confirmed to be glucose 
using TLC against reference standard. Compound 3 was also 
subjected to acetylation using pyridine and acetic anhydride and 4 
methyl groups were observed in the 1HNMR spectra in the region 
between (1.9-2.1 ppm) corresponding to 4 acetyl groups of the sugar 
moiety. 
Molecular docking was carried as follows, The X-ray crystallographic 
structure of TNF complexed with a small molecule inhibitor (PDB 
Code: 2az5) was obtained from the RCSB Protein Data Bank. The 
three dimensional structure of ergostane 1 and TNF inhibitor 
marketed by sigma-Aldrich®
The steroidal skeleton reported previously for ginsenosides can 
have hydrophobic interaction with the residues located inside the 
pore of TNF at Cys69, Pro100, Cys101, Ala109, Pro113 and Trp114 
[7]. Compound 1 binding energy was-86.9, it showed hydrogen bond 
with six amino acid residues, TYR 110, LEU 111, GLY 112, GLY 45, 
LEU 46 and GLN116 (fig. 1). 
[11] was derived by Avogadro software. 
The accurate docking was performed using the docking tool 
iGEMDOCK v2.0 based on the binding energy in kcal/mol. Numbers 
of runs taken are 80 and maximum interactions were 2000 with 
population size 200 and with an energy threshold of 100. Also at 
each step least ‘minimum’ torsions/translations/rotations are tested 
and the one giving lowest energy is chosen. The hydrophobic 
preference and electrostatic preference were set to 1.00. The 
binding site of the target was identified at a distance 8 A °. 
 
Fig. 1: Predicted binding model of compound 1 to 2AZ5 and 
binding models of 2AZ5 was shown as a ribbon drawing. The 
side chains of the active site residues and compound 1 are 
represented as stick model 
 





 as TNF inhibitor [10], (fig. 2) which 
showed binding energy-117.3 with only one hydrogen bond with 
amino acid residue SER 86, and VAN DER WAAL forces with GLU 44, 
TYR78, GLN 116, GLU 118, VAL 82, ASN 83, SER 86 and ILE 88. Thus, 
although the compound marketed by sigma showed lower energy, 
but actually it binds with only one amino acid residue compared to 
six amino acid residues in the case of compound 1. 
  
A B 




A new ergostane was isolated from Cleome droserifolia and 
identified as ergost-5,7,9,24(28)-tetraen-3-one. Computational 
studies has proven its TNF inhibition effect which indicates its 
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